Moreover, the results demonstrated the discriminatory ability of IL-4 in EOS patients with NSS versus healthy controls (AUC = 0.91) and the combination of IL-4, IL-6 and IL-12 was result in a significant discriminant (AUC = 0.95). The gene discussed is IL4; the disease is Blau syndrome.